Study of LRG-002 Hard Capsules (Lek d.d., Slovenia) Used in the Prophylaxis of Antibiotic-associated Diarrhea in Adults.
Status:
Completed
Trial end date:
2021-01-04
Target enrollment:
Participant gender:
Summary
The goal of this study is to investigate the efficacy and safety of LRG-002 investigational
medicinal product, capsules (Lek d.d., Slovenia) in comparison with placebo, as an adjunct
treatment for prophylaxis of antibiotic-associated diarrhea (AAD) in patients with acute
respiratory diseases (ARDs) receiving a standard antimicrobial therapy.